Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annie Lorence

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|October 5, 2012
France's new framework for regulating off-label drug useJoseph Emmerich, Nathalie Dumarcet, Annie Lorence
European Journal of Cancer (Oxford, England : 1990)|April 10, 2021
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 yearsEmmanuelle Jacquet, Ghania Kerouani-Lafaye, Francoise Grude, et al.
Cancer|March 25, 2021
Access to innovation through the national early access program and clinical trials for patients with malignant melanomaClaire Christen, Laetitia Belgodère, Bernard Guillot, et al.
Nature Reviews. Drug Discovery|May 3, 2011
European regulation on orphan medicinal products: 10 years of experience and future perspectives, Kerstin Westermark, Birthe Byskov Holm, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|October 5, 2012
France's new framework for regulating off-label drug useJoseph Emmerich, Nathalie Dumarcet, Annie Lorence
European Journal of Cancer (Oxford, England : 1990)|April 10, 2021
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 yearsEmmanuelle Jacquet, Ghania Kerouani-Lafaye, Francoise Grude, et al.
Cancer|March 25, 2021
Access to innovation through the national early access program and clinical trials for patients with malignant melanomaClaire Christen, Laetitia Belgodère, Bernard Guillot, et al.
Nature Reviews. Drug Discovery|May 3, 2011
European regulation on orphan medicinal products: 10 years of experience and future perspectives, Kerstin Westermark, Birthe Byskov Holm, et al.
Pageof 1